No Data
Jinhai Medical Technology to Move Headquarters to China
Today, Honghai Medical (02225) was awarded the Golden Hong Kong Stock "Most Valuable Pharmaceutical and Medical Company", with annual highlights frequently emerging.
At the "9th Zhito Finance Capital Markets Annual Conference and Award Ceremony for Listed Companies", Jin Hai Medical was awarded the honor of "Most Valuable Medical and Healthcare Company".
JINHAI MED TECH (02225): The stock split will take effect on December 12.
JINHAI MED TECH (02225) announced that all the conditions precedent for the share split have been fulfilled, and the share split will take place...
SFC Finds High Concentration of Shareholding in Jinhai Medical Technology, Unusual Share Price Movement
Jinhai Medical's High Shareholding Concentration Raises Volatility Concerns
JINHAI MED TECH (02225.HK) has a highly concentrated equity structure.
On December 9, Gelonghui reported that jinhai med tech (02225.HK) announced that the China Securities Regulatory Commission recently inquired about the company's shareholding distribution. The inquiry results showed that as of November 20, 2024, there are twenty-seven shareholders and their related parties collectively holding 0.53328 billion shares of the company, accounting for 41.26% of the company's issued share capital. This shareholding together with the 0.6325 billion shares held by the company’s chairman and executive director (which accounts for 48.94% of the issued share capital) amounts to 90.20% of the company's issued share capital. Therefore, the company has only 0.12672 billion shares.
There's Reason For Concern Over Jinhai Medical Technology Limited's (HKG:2225) Massive 31% Price Jump
